| Product Information |
|
| Registration Number |
DR-XY45789
|
| Generic Name |
Eribulin Mesilate
|
| Brand Name |
Halaven
|
| Dosage Strength |
500mcg/mL (1mg/2mL)
|
| Dosage Form |
Solution For Injection (IV)
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Antineoplastic agent
|
| Packaging |
5 mL-capacity USP Type I Clear Glass vial x 2 mL (net
content) with gray butyl rubber stopper and blue colored aluminum flip-off seal (Box of 1's)
|
| Manufacturer |
BSP Pharmaceuticals S.P.A.
|
| Country of Origin |
Italy
|
| Trader |
N/A
|
| Importer |
Hi-Eisai Pharmaceutical, Inc.
|
| Distributor |
Zuellig Pharma Corporation
|
| Application Type |
Initial (from Monitored release)
|
| Issuance Date |
02 September 2022
|
| Expiry Date |
22 February 2027
|